dedup-isc-ft-v107-score
float64
0.3
1
uid
stringlengths
32
32
text
stringlengths
1
17.9k
paper_id
stringlengths
8
11
original_image_filename
stringlengths
7
69
0.423432
c58be7eed04f4cf3a631472c793d45c4
Forest plot of the effect of Pulmonary Rehabilitation in post-acute patients with COVID-19 related to physical function, dyspnea, and quality of life. (A) RCTs assessed; (B) Observational studies assessed.
PMC9776761
diagnostics-12-03032-g003.jpg
0.490079
4277cb3ccace48be826747b47945625f
Leave-one-out analysis of the effect of Pulmonary Rehabilitation in post-acute patients with COVID-19 related to physical function, dyspnea, and quality of life. (A) RCTs assessed; (B) Observational studies assessed.
PMC9776761
diagnostics-12-03032-g004.jpg
0.46038
3bde7be135be457682145bc0dd5b3947
Subgroup meta-analysis of the effect of Pulmonary Rehabilitation in post-acute patients with COVID-19 related to physical function, dyspnea, and quality of life. (A) RCTs assessed; (B) Observational studies assessed.
PMC9776761
diagnostics-12-03032-g005.jpg
0.514337
34a6111c1f6d45ff8aba464ebc627ae0
Publication bias of included studies on the effect of Pulmonary Rehabilitation in post-acute patients with COVID-19 related to physical function, dyspnea, and quality of life. (A) RCTs assessed; (B) Observational studies assessed.
PMC9776761
diagnostics-12-03032-g006.jpg
0.408267
15f199f9f1924a4fa7d6420b7ef94461
Protocols of TN-IMS measurement. (A) The TN-IMS system is in contact with a suspected thyroid nodule via two electrodes, a needle probe inside the nodule, and an ECG chest lead connected to the submental region. (B) The pathological structure of normal thyroid tissue is illustrated through an H&E assay and a schematic picture. (C) Pathological structure of a cancerous thyroid nodule presented by an H&E assay [27]. Inclusions and Orphan Annie-eye nuclei patterns are illustrated in a schematic. (D) The intraoperative application of TN-IMS needle probe.
PMC9776834
diagnostics-12-02950-g001.jpg
0.503303
8cb1d0f37ea2448d98f291865639bed9
The study flow diagram shows patient exclusion.
PMC9776834
diagnostics-12-02950-g002.jpg
0.494871
f06a029356504b2087f7327f2d4706b4
TN-IMS calibration and scoring. (A) A two-dimensional diagram representing Z1kHz on X-axis and IPS on Y-axis for all tested samples defines a primary calibration cut-off set. The patterned rectangle illustrates the positive region with the most malignancy probability in thyroid samples. (B) The classification criteria for positive thyroid nodules. (C) The effect of changing calibration features cut-offs in AUC, sensitivity, and specificity. Most AUC and sensitivity/specificity compositions belong to the primarily defined calibration cut-offs. (D) Comparison of AUC, sensitivity, and specificity of clinical indications such as age, sex, nodule size, TI-RADS, Bethesda, and TN-IMS scores in all tested samples (including thyroid nodules and normal thyroid tissues). (E) AUC, sensitivity, and specificity of clinical indications such as age, sex, nodule size, TI-RADS, Bethesda, and TN-IMS score in only thyroid nodules.
PMC9776834
diagnostics-12-02950-g003.jpg
0.377336
86ebd9d2314e4c82bde66343e0d854b6
Picture of H&E assays of nodules correctly diagnosed with TN-IMS. (A) PTC. (B) Micro-PTC. (C) HT. (D) Colloid goiter.
PMC9776834
diagnostics-12-02950-g004.jpg
0.367354
04785ee13ec5435194e04268d848d456
Effect of esculetin on t-BHP-induced HEK293 cell injury. The cell viability of HEK293 cells exposed to different concentrations of esculetin (A), t-BHP (B) and t-BHP with esculetin (C). In the bar graphs, the values represent means ± SD, n = 5. * p < 0.05 vs. untreated control group, # p < 0.05 vs. t-BHP-treated control group.
PMC9777115
cimb-44-00407-g001.jpg
0.407308
240bc2c4af8949f7b4ddde63b8570f72
Effect of esculetin on t-BHP-induced ROS generation in HEK293 cells. (A) The changes in ROS levels in HEK253 cells exposed to t-BHP with esculetin were detected using DCFH-DA dye. (B) In the bar graphs, the values represent means ± SD, n = 5. * p < 0.05 vs. untreated control group, # p < 0.05 vs. t-BHP-treated group.
PMC9777115
cimb-44-00407-g002.jpg
0.433005
ec40e4ab1b424b989bfe98abd8d8bbdd
Effect of esculetin on t-BHP-induced apoptosis in HEK293 cells. (A) Apoptosis of HEK253 cells exposed to t-BHP with esculetin were detected using TUNEL staining. (B) In the bar graphs, the values represent means ± SD, n = 5. * p < 0.05 vs. untreated control group, # p < 0.05 vs. t-BHP-treated group.
PMC9777115
cimb-44-00407-g003.jpg
0.418544
3b0ff993496f46bea5573b8052296410
Effect of esculetin on apoptosis-related signaling pathways in HEK293 cells. (A) Apoptosis-related protein assay. (B) In the bar graphs, the values represent means ± SD, n = 5. * p < 0.05 vs. untreated control group, # p < 0.05 vs. t-BHP-treated group.
PMC9777115
cimb-44-00407-g004.jpg
0.557607
9f9563bce55b4842ade7f2e7f672da4b
Effect of esculetin on the expression of apoptosis-related mRNA in HEK293 cells. The mRNA expression levels of Bax, bcl-2, caspase-3 and PARP. In the bar graphs, the values represent means ± SD, n = 5. * p < 0.05 vs. untreated control group, # p < 0.05 vs. t-BHP-treated group.
PMC9777115
cimb-44-00407-g005.jpg
0.478197
9ef5083b57d64b6d9d697530e5eea69f
Effect of esculetin on the expression of apoptosis-related proteins in HEK293 cells. The protein expression levels of Bax, bcl-2, cleaved caspase-3 and cleaved PARP. In the bar graphs, the values represent means ± SD, n = 5. * p < 0.05 vs. untreated control group, # p < 0.05 vs. t-BHP-treated group.
PMC9777115
cimb-44-00407-g006.jpg
0.453917
b36bd5f8279e4da58ddcb8d25f387c75
Block diagram of the proposed algorithm.
PMC9777432
diagnostics-12-03084-g001.jpg
0.502907
a4b705bfbb754e8fa9d19c68dfb95515
Pre-processing phase of input image.
PMC9777432
diagnostics-12-03084-g002.jpg
0.464498
7ddc149bd0784114984c6b57807c0da2
Effect of applying CLAHE; (a) original; and (b) CLAHE processed.
PMC9777432
diagnostics-12-03084-g003.jpg
0.39366
7868be676ea14db790e378f233ee6349
Custom design lightweight CNN architecture.
PMC9777432
diagnostics-12-03084-g004.jpg
0.467197
ca34589c5a194f6789de7d2c06859925
Framework 1-cascaded classifier architecture.
PMC9777432
diagnostics-12-03084-g005.jpg
0.434532
f3021297547040748ddbe0630b2c46ba
Framework 2-Ensembled System Design.
PMC9777432
diagnostics-12-03084-g006.jpg
0.546287
fdcb4e621f2a4e47a43e4cb10f32cf62
Framework 3-LSTM working [34].
PMC9777432
diagnostics-12-03084-g007.jpg
0.415198
d6282fe064bf47ecb38b046a4276b5dc
Performance comparison of all three proposed frameworks using augmented data.
PMC9777432
diagnostics-12-03084-g008.jpg
0.438081
5703fc62584540bebe2c01a69f5d8c9c
Performance comparison of proposed frameworks against augmented vs. non-augmented training dataset.
PMC9777432
diagnostics-12-03084-g009.jpg
0.474933
a94a3f2bf37a4dfda76d738b6a191a47
Gene expression pattern with each GSE dataset and clustering of DEGs heat map of overlapping genes. (A) The volcano plot shows gene expression distribution of the microarray data in GSE36295, (B) GSE36693, and (C) GSE65216. The data was cut-off based on p-value < 0.01 and fold change (FC) log > 1. X-axis and y-axis present fold change log and log-transformed p-value, respectively. (D) Venn diagram for intersection of all up-regulated and down-regulated DEGs of GSE36295, GSE36693, and GSE65216 using the FunRich program. (E) Heat map exhibiting expression changed genes of up-regulated and down-regulated DEGs using GraphPad.
PMC9777496
cimb-44-00398-g001.jpg
0.477488
d0be826e12a84f2ba5db254582de88d2
PPI network of DEGs. (A) PPI network of up-regulated and (B) down-regulated genes created by the STRING site. (C) Clustering analysis of up-regulated DEGs and (D) down-regulated DEGs for selecting hub genes using the MCODE plug-in in cytoscape.
PMC9777496
cimb-44-00398-g002.jpg
0.495818
203af343131843748495e6aef21fb043
Survival rate analysis between TNBC patients and up-regulated and down-regulated genes. (A) The correlation of survival rate and up-regulated MCM4, CDC7, CCNB2, and CHEK1 gene expression in TNBC patients. (B) The correlation of survival rate and down-regulated CXCL12, IL6ST, and IGF1 gene expression in TNBC patients.
PMC9777496
cimb-44-00398-g003.jpg
0.433502
0abffea72e354344b5a32679b2da7cac
Comparison of DEGs expression between non-TNBC and TNBC patients or cell lines. (A) The comparison of up-regulated DEGs, MCM4, CDC7, CCNB2, and CHEK1, in Healthy, non-TNBC, and TNBC from GSE65216. (B) The comparison of down-regulated DEGs, CXCL12, IL6ST, and IGF1, in Healthy, non-TNBC, and TNBC. (C) The mRNA expression comparison of up-regulated DEGs, MCM4, CDC7, CCNB2, and CHEK1, in non-TNBC cells and TNBC cells, which are MCF-7 and MDA-MB231. (D) The mRNA expression comparison of down-regulated DEGs, CXCL12, IL6ST, and IGF1, in non-TNBC cells and TNBC cells, which are MCF-7 and MDA-MB231. Columns are presented with the mean of SEM. Statistical analysis using one-way ANOVA was performed in (A,B), and t-test performed in (C,D); * p < 0.05, ** p < 0.005, *** p < 0.0005, **** p < 0.0001 vs. control in each group, n.s.: nonsignificant.
PMC9777496
cimb-44-00398-g004.jpg
0.419047
98ca2607f638488faf072f88b5b84c45
The expression of CHK1 protein according to breast cancer subtypes. (A) CHK1 protein expression level with basal-like subtype of breast patients versus HER2-positive, luminal A, and luminal B from ‘The cancer proteome atlas’. (B) CHK1 protein expression comparison graph from ‘The cancer proteome atlas’. (C) The survival rate of breast cancer patients according to CHK1 protein expression using the KM plotter website. (D) Western blotting of CHK1 in non-TNBC cell lines, including MCF-7 and T47D, and TNBC cell lines, including MDA-MB453, MDA-MB231, BT549, and Hs578T. (E) The graph showing quantification of CHK1 expression normalized with endogenous GAPDH through Graphpad. Columns are presented with the mean of SEM. Statistical analysis using t-test was performed by comparing non-TNBC and TNBC; ** p < 0.005 vs. control in each group.
PMC9777496
cimb-44-00398-g005.jpg
0.434286
d90521cd7617418d8334eb5f107d62aa
CHK1 induced epithelial to mesenchymal transition (EMT) in breast cancer cells. (A) The correlation of CHK1 with CDH1 and OCLN, which are epithelial marker genes. (B) Western blotting of EMT marker proteins in control and CHK1-overexpressing MCF-7 cells. (C) Fluorescence of phalloidin for observation of the morphology in control and CHK1-overexpression MCF-7 cells. (D) Migration assay with control and CHK1-overexpression MCF-7 cells for 48 h after scratch. (E) Transwell invasion assay with control and CHK1-overexpression MCF-7 cells for 48 h after incubation. (F) Western blotting of EMT marker proteins in control and CHK1-knockdown MDA-MB231 cells. (G) Fluorescence of phalloidin for observation of the morphology in control and CHK1-knockdown MDA-MB231 cells. (H) Migration assay with control and CHK1-knockdown MDA-MB231 cells for 16 h after scratch. (I) Transwell invasion assay with control and CHK1-knockdown MDA-MB231 cells for 12 h after incubation. Columns are presented with the mean of SEM. Statistical analysis using t-test was performed by comparing HA-Con and HA-CHK1 or siCon and siCHK1; * p < 0.05, ** p < 0.005, *** p < 0.0005, **** p < 0.0001 vs. control in each group.
PMC9777496
cimb-44-00398-g006.jpg
0.461017
7603b0ada8c64678836b748a89953b45
Viscosity of myofibrillar protein mixtures with various additional levels of gelatin and transglutaminase.
PMC9777981
gels-08-00822-g001.jpg
0.477619
bd7007e8efde42eb8c257dbef43ffcfb
SDS-PAGE of myofibrillar protein mixtures with various additional levels of gelatin and transglutaminase.
PMC9777981
gels-08-00822-g002.jpg
0.481151
72b3dff0149e4088b6fdc28cf2939267
Microstructure of myofibrillar protein mixtures with various additional levels of gelatin and transglutaminase (TGase). (a) Control. (b) Gelatin 0.5 g/100 g. (c) Gelatin 1.0 g/100 g. (d) Gelatin 1.5 g/100 g. (e) Control with TGase. (f) Gelatin 0.5 g/100 g with TGase. (g) Gelatin 1.0 g/100 g with TGase. (h) Gelatin 1.5 g/100 g with TGase.
PMC9777981
gels-08-00822-g003.jpg
0.412353
aa014106dbaa4e18963bd62351fe667a
Cooking loss (g/100 g) of restructured ham with gelatin and transglutaminase. a,b Means (n = 3) with the same superscripts in the same row are not different (p > 0.05).
PMC9777981
gels-08-00822-g004.jpg
0.57163
e873a015f8224c3e98aa81d09549ae37
Expressible moisture (a) and Allo–Kramer value (b) of restructured ham with gelatin and transglutaminase. a–c Means (n = 3) with the same superscripts in the same row are not different (p > 0.05).
PMC9777981
gels-08-00822-g005.jpg
0.458541
2a8c410b6dee4d91aa60f5b774c6dda8
FTIR of restructured ham with gelatin and transglutaminase.
PMC9777981
gels-08-00822-g006.jpg
0.4708
0b8c685132224e39a66569d8f13b6cac
Protein surface hydrophobicity (H0) and the contents of peptides by sulfhydryl (-SH) groups on restructured ham with gelatin and transglutaminase. a,b Means (n = 3) with the same superscripts in the same row are not different (p > 0.05).
PMC9777981
gels-08-00822-g007.jpg
0.498631
36f2ce29d5194cc091270ffe4421cea3
Effects of different treatments on MP gel strength and WHC, the bands from left to right are the control group, 1% KSDF–MP treated with ultrasonic energy at 0 W, 200 W, 400 W, and 600 W, respectively, different letters in the same indicator indicate significant differences (p < 0.05).
PMC9778066
foods-11-03998-g001.jpg
0.566927
638a7c6138ad4916a549bcff23756430
Storage modulus (G’) of MP gel with different treatments.
PMC9778066
foods-11-03998-g002.jpg
0.443717
8965a50418064da6aecefe9a90834c36
Effects of different groups on the water relaxation time (A) and relative content of water with different states of composite gels (B).
PMC9778066
foods-11-03998-g003.jpg
0.426164
be46c8f73e724fed8fc48d75ab5b7e45
SEM photographs of the different treatment groups on MP gel, (A–E) indicate the gel with CK, 1%, 1%-0 W, 1%-200 W, 1%-400 W, and 1%-600 W, respectively.
PMC9778066
foods-11-03998-g004.jpg
0.469334
05901b3d0b4f489190ec15fe353132da
Effect of different treatments on the solubility (A), surface hydrophobicity (B), and total sulfhydryl groups (C). Different letters at solubility, BPB bound content and Total SH differ significantly (p < 0.05).
PMC9778066
foods-11-03998-g005.jpg
0.445369
f4a82b2e671a4a8894e7219ebbb5f6ec
SDS-PAGE of MP samples with different treatments (A), the MP gels after different treatments (B).
PMC9778066
foods-11-03998-g006.jpg
0.437874
e845a5af5a254e2194b79bb8231e359e
Effect of different treatments on the FTIR (A) and secondary structure (B) of MP. Different letters in the same color group represent significant differences (p < 0.05).
PMC9778066
foods-11-03998-g007.jpg
0.457678
b90c262d48fa40f4a5cd9f4de41bc475
Effect of different treatments on MP chemical forces. A-D indicate the content of ionic bond, hydrogen bond, hydrophobic interaction and disulfide bond for different groups of samples, respectively. Different letters indicate significant differences between the chemical forces of samples from different groups (p < 0.05).
PMC9778066
foods-11-03998-g008.jpg
0.446234
60a5ac9980b341dcbacdf46e33cd2858
Clinical presentation of our patient.
PMC9778367
genes-13-02266-g001.jpg
0.382567
8f938a5375464a91861f73f3efbff548
(a) Pedigree of the family; (b) analysis of X chromosome inactivation in our patient: fragment analysis results for the AR locus. Fragment analysis of undigested (− HpaII) and digested (+ HpaII) DNA from the proband (II:1) and her father (I:1). After HpaII digestion, DNA from the male individual (I:1) cannot be amplified with PCR, while DNA from the proband shows a skewed (about 87%) X chromosome inactivation.
PMC9778367
genes-13-02266-g002.jpg
0.447747
595bf39cfb4c46f888703073821c62e4
Schematic structure of the KDM5C gene and its known pathogenic variants. Exons are in scale; introns are not in scale. Exons belonging to isoform NM_004187.5 are shown by grey rectangles. The mutation found in the present patient is shown with a grey background. Truncating (i.e., nonsense and frameshift) and splicing variants are shown at the top, while non-synonymous and in-frame alterations are shown at the bottom. E: exon. Proteins’ functional domains are shown as colored rectangles under the gene scheme and include ARID: helix–turn–helix motif-based DNA-binding domain; JmjC: catalyzes demethylation of H3K4me3 to H3K4me1 JmjN: interacts with JmjC PHD: histone-methyl-lysine binding motif.
PMC9778367
genes-13-02266-g003.jpg
0.438167
4c5bc98b53024e6fb37d3e2575881cec
Minor allele frequency (MAF) of 180 genotyping array markers throughout the gene regions of (a) NEBL chr2:11,650,000 to chr2:12,650,000, (b) LPHN2 chr6:65,109,000 to chr6:66,110,000, (c) HDGFL1 chr7:40,745,000 to chr7:41,746,000, (d) SORBS2 chr16:44,526,000 to chr16:45,527,000 and (e) HTR1F chr31:0 to chr31:773,000. (f) Gene regions marked across the x-axis, with variant locations marked above.
PMC9778376
genes-13-02292-g001.jpg
0.443238
0779e88204b8458098a7224a4b03f27f
Characteristics of 180 Cavalier King Charles Spaniels (CKCS) at two low diversity loci as assayed using genotyping arrays. (a) Minor allele frequency (MAF) throughout the NEBL gene region chr2:11,650,000 to chr2:12,650,000, (b) MAF throughout the HDGFL1 region chr7:40,745,000 to chr7:41,746,000. (c) Regional pairwise linkage disequilibrium by r2 (LD) (grey dots) with the NEBL3 variant at chr2:11 979 724 (red dot) and other NEBL variant loci shown as blue dots. (d) Regional pairwise LD (grey dots) with the HDGFL1 variant predictor chr7:41 248 384 (coding variant at 7:41 245 057) (blue dot). Shaded regions represent the respective gene spans.
PMC9778376
genes-13-02292-g002.jpg
0.441945
a4654383f420478f8cd471d16ddadd4a
Comparison of age-adjusted LA:Ao measurements for 178 CKCSs at variant representative array markers for (a) HDGFL1 (b) NEBL1-3 (NEBL1, NEBL2 and NEBL3 grouped as they are in perfect LD, see Figure 2) (c) NEBL4 (d) NEBL5 and (e) NEBL6. Plots include median line, mean marker and quartile ranges. Alternate homozygote was only observed at HDGFL1 predictive array marker.
PMC9778376
genes-13-02292-g003.jpg
0.40691
71e346f41b5e45dab2ea6aec3510f8c4
Comparison of age-adjusted LVIDdN measurements for 178 CKCSs at variant representative array markers for (a) HDGFL1 (b) NEBL1-3 (NEBL1, NEBL2 and NEBL3 grouped as they are in perfect LD, see Figure 2) (c) NEBL4 (d) NEBL5 and (e) NEBL6. Plots include median line, mean marker and quartile ranges. Alternate homozygote was only observed at HDGFL1 predictive array marker.
PMC9778376
genes-13-02292-g004.jpg
0.46992
dc0a4a47a93448ef9e7670742ac88b00
PRISMA Flow Diagram on selection and inclusion of studies.
PMC9779018
ijerph-19-16722-g001.jpg
0.417259
9fe72e4094434c1b92afbcb97822adee
(a,b): showing risk of bias graph (a) and risk of bias summary (b) of included studies [29,30,31,33,34,35,36,37].
PMC9779018
ijerph-19-16722-g002a.jpg
0.418246
8999586c11874ddc98b6189aa6852576
Location of the accident site: (a) Guizhou Province in China; (b) Qiandongnan Miaodong autonomous prefecture; (c) The disaster site in Rongjiang County, Guizhou Province; (d) Satellite image of the accident site.
PMC9779358
ijerph-19-17003-g001.jpg
0.471455
74a2d0c8c7c44e9fb450adcb7daef09e
Accident scene (Source: https://www.163.com/dy/article/H9PN38TB0552ZFBN.html, accessed on 4 June 2022).
PMC9779358
ijerph-19-17003-g002.jpg
0.472858
b73de37542cc43e7af87aeae305e4ccb
Rescue operation: (a) Firefighters rescuing trapped people; (b) Staff cleaning up the accident train; (c) Track debris flow removal; (d) Clearing debris flow intruding into the line (Source: Xinhua News Agency https://haokan.baidu.com/v?pd=wisenatural&vid=2796812779194810025, accessed on 24 June 2022).
PMC9779358
ijerph-19-17003-g003.jpg
0.408734
2a46f556ee624f8bb9a44644e343a167
Accident simulation analysis diagram.
PMC9779358
ijerph-19-17003-g004.jpg
0.461266
2254c329d32c402983c5c8d78492525f
Different types of debris flow under different terrain conditions.
PMC9779358
ijerph-19-17003-g005.jpg
0.437429
54f7a94d2f1f495eafc02dd2813c5131
Rainfall situation: (a) Rain warning map of Rongjiang County the day before the accident; (b) Rainfall in Rongjiang County within 12 h by time.
PMC9779358
ijerph-19-17003-g006.jpg
0.557043
67cf840607d846baba282de744a71d82
Logic diagram of debris flow analysis and judgment that caused this derailment accident.
PMC9779358
ijerph-19-17003-g007.jpg
0.395321
95b60f00ac544a2faa181d11ea64e6df
Safeguard: (a) Rongjiang Station tunnel exit; (b) protective facilities for Xi’an Chengdu Railway Construction to prevent rockfall.
PMC9779358
ijerph-19-17003-g008.jpg
0.520654
e3bd971334204fdeb82202b749924d92
Flow chart of landslide debris flow warning.
PMC9779358
ijerph-19-17003-g009.jpg
0.580811
26e9095e072642c3af3fa2829cf7b51a
Evaluation index system of debris flow risk in hydropower project.
PMC9779358
ijerph-19-17003-g010.jpg
0.471104
3b23b4bb9c994674ac9fcbfa03bb2184
Molecular structure of 7. Hydrogen atoms (except hydrogen atom on N(2)) and solvate molecule of toluene omitted for clarity. Selected bond Lengths (Å) and angles (deg) for 7: Ga(1)-O(3A) 1.839(14), Ga(1)-O(1) 1.874(3), Ga(1)-O(2) 1.878(3), Ga(1)-O(3B) 1.89(2), Ga(1)-N(2) 2.091(5), Ga(1)-N(1) 2.119(4), O(3A)-Ga(1)-O(1) 118.7(4), O(3A)-Ga(1)-O(2) 108.6(4), O(1)-Ga(1)-O(2) 132.65(15), O(1)-Ga(1)-O(3B) 108.9(6), O(2)-Ga(1)-O(3B) 118.3(6), O(3A)-Ga(1)-N(2) 98.7(5), O(1)-Ga(1)-N(2) 88.54(18), O(2)-Ga(1)-N(2) 82.62(17), O(3B)-Ga(1)-N(2) 98.6(5), O(3A)-Ga(1)-N(1) 95.9(5), O(1)-Ga(1)-N(1) 89.12(15), O(2)-Ga(1)-N(1) 87.71(14), O(3B)-Ga(1)-N(1) 96.7(5), N(2)-Ga(1)-N(1) 164.46(17).
PMC9779430
ijms-23-15649-g001.jpg
0.534394
6de8d5999a904b2fb47708e49f32eedd
Synthesis of complexes 4–6.
PMC9779430
ijms-23-15649-sch001.jpg
0.49961
4025ad4520104d2f8b61e3ec079395b2
The plausible synthetic way for the formation of complex 7.
PMC9779430
ijms-23-15649-sch002.jpg
0.489108
27e799bdf478478e9e5d5e2c763e6e37
Weighted gene co-expression network analysis (WGCNA). (A) The Gene clustering tree (dendrogram) in OB. (B) Module–trait relationships in OB. Each cell contains the corresponding correlation and p-value. (C) The Gene clustering tree (dendrogram) in AD. (D) Module–trait relationships in AD. Each cell contains the corresponding correlation and p-value. OB, obesity; AD, Alzheimer’s disease.
PMC9780446
fendo-13-1072955-g001.jpg
0.394549
0f3c80389570471b923f4b363c3e295d
GO enrichment analysis of the modular genes. (A) The GO biological process analyses of three positive OB-related modules. (B) The GO biological process analyses of two negative OB-related modules. (C) The GO biological process analyses of one positive AD-related modules. (D) The GO biological process analyses of three negative AD-related modules. OB, obesity; AD, Alzheimer’s disease; GO, gene ontology.
PMC9780446
fendo-13-1072955-g002.jpg
0.479611
0eef421f81114941ba565d29923c38e1
Venn diagram and GO enrichment analysis. (A) The shared genes between positive OB related and AD related modules. (B) GO analysis of shared genes between positive OB related and AD related modules. (C) The shared genes between negative OB related and AD related modules. (D) GO analysis of shared genes between negative OB related and AD related modules. OB, obesity; AD, Alzheimer’s disease.
PMC9780446
fendo-13-1072955-g003.jpg
0.459322
fece3da00a20458289127751ffcc1902
PPI network and co-expression network of hub genes. (A) PPI network diagram of GS1-UP. (B) GeneMANIA analysis of hub genes and their co-expression genes in GS1-UP. (C) PPI network diagram of GS1-DOWN. (D) GeneMANIA analysis of hub genes and their co-expression genes in GS1-DOWN. GS1, gene set 1.
PMC9780446
fendo-13-1072955-g004.jpg
0.415735
2de90c215a644b01b20991af87f8b3a0
Venn diagram and enrichment analysis of the common DEGs. (A) The Venn diagram of the upregulated genes in GSE44000 and GSE122063. (B) The GO biological process analyses of common-upregulated genes. (C) The KEGG pathway of common-upregulated genes. (D) The Venn diagram of the downregulated genes in GSE44000 and GSE122063. (E) The GO biological process analyses of common-downregulated genes. (F) The KEGG pathway of common-downregulated genes. GO, gene ontology; DEGs, differentially expressed genes.
PMC9780446
fendo-13-1072955-g005.jpg
0.428843
cec7421ec15c4d6bb5e4d1f8fd7a76f9
Confirmation of the different expression of candidate targets in animal models. (A–E) AD mice were subjected to hippocampal-dependent cognitive testing using the MWM. Data in (A, B) show the MWM training and data in (C, D) show the MWM testing. Data in (E) show mice swimming speeds. (F) Weight in in WT and OB mice. (G) The expressions of Mmp9, Pecam1, C3ar1, Il1r1, Ppargc1α, and Coq3 were analyzed by qPCR analysis in cortex tissues from AD and NC mice. (H) The expressions of Mmp9, Pecam1, C3ar1, Il1r1, Ppargc1α, and Coq3 were analyzed by qPCR analysis in subcutaneous adipose tissues from OB and WT mice. MWM, Morris water maze; WT, wild type; OB, obesity; NC, negative control; AD, Alzheimer’s disease. *p <0.05, **p <0.01, ***p <0.001.
PMC9780446
fendo-13-1072955-g006.jpg
0.458595
652ab4725b044fdd9840025a3263acd8
Vertical distribution patterns of the venerable trees in Sichuan in relation to: (a) tree abundance, and (b) species richness. The scatter points were fitted using a linear function.
PMC9780929
plants-11-03581-g001.jpg
0.452103
6421b1ebe0c44324bb461cbf305ba755
Ordination of geographical distribution and bioclimatic factors of venerable trees in Sichuan using redundancy analysis (RDA). See Table S1 for the meaning of bioclimatic factors. The solid arrowhead indicates the longitude and latitude as the dependent variable, and the hollow arrowhead indicates the bioclimatic factor as the independent variable. The included angle indicates the correlation (acute angle for positive correlation, obtuse angle for negative correlation, and right angle for no correlation).
PMC9780929
plants-11-03581-g002.jpg
0.422349
05455ad794f54213aca120b2f56d40b8
Distribution pattern of six categories of habitat suitability of venerable trees in Sichuan based on the current climate scenario. The results were obtained from the model predictions of BIOCLIM using DIVA-GIS. Different colors, from grey to red, denote the gradation from not suitable to excellent habitat suitability, and hence the probability of tree occurrence. The A, B and C annotations indicate the three largest patches of excellent suitability.
PMC9780929
plants-11-03581-g003.jpg
0.463735
2cfc4f6b06b34731a38e54cb7fc9cb5e
The potential biogeographical range of venerable trees in Sichuan under a future climate change scenario (double CO2 concentration according to the CCM3 model). Habitat suitability is classified into six categories denoted by different colors. The A, B and C annotations indicate the locations with a concentration of excellent habitat suitability.
PMC9780929
plants-11-03581-g004.jpg
0.43922
42bf11d5fcdd422c9ba0708873456956
Photographs of main venerable trees and their habitats in Sichuan Province. Photo (A–C) and (E,F) denote Cupressus funebris (Cupressaceae); (D) and (H) Ginkgo biloba (Ginkgoaceae); (G) Machilus nanmu (Lauraceae); (I) Cinnamomum camphora (Lauraceae); (J) Pterocarya stenoptera (Juglandaceae); and (K) Morus australis (Moraceae).
PMC9780929
plants-11-03581-g005.jpg
0.456513
4b89c78f30b041d4a776cf14d26a4a38
Prolactinoma with bleeding areas inside. Pituitary MRI at diagnosis. (a). Noncontrast sagittal T2-weighted image. (b). Noncontrast coronal T2-weighted image. (c). Noncontrast sagittal T1-weighted image—diffuse bleeding (hyper T1—arrows). (d). Postcontrast sagittal T1-weighted image. (e). Postcontrast coronal T1-weighted image. (f). Postcontrast coronal T1-weighted image. Pituitary fossa—anteroposterior diameter: 13 mm; transverse diameter: 17 mm; oval-shaped lesion 12.8/10 mm; heterogeneous high-signal T2-weighted (a,b); T1-weighted (c,d), located in the adenohypophysis with high signal in T1; weighted areas corresponding to the subacute intratumoral hemorrhage due to the presence of methemoglobin, heterogeneous enhancement (e,f), extending superiorly to the pituitary fossa (b,d,e,f) with mild compression of the optic chiasma (b,d,f).
PMC9780970
jpm-12-02061-g001.jpg
0.431312
ceea9b634c4a40ef88d3067ecc27e449
Pituitary MRI performed 4 years later when the patient was 6 weeks pregnant. (a). Non-contrast sagittal T2-weighted image. (b). Non-contrast coronal T2-weighted image. (c). Non-contrast sagittal T1-weighted image. (d). Non-contrast coronal T1-weighted image. (e). Post-contrast sagittal T1-weighted image. (f). Post-contrast coronal T1-weighted image. Favorable evolution of the pituitary adenoma located in the left parapituitary in moderate high-signal T2-weighted (a,b), low-signal T1-weighted (c,d), and non-gadolinium enhanced (e,f) with dimensions reduced to 2.1/2 mm.
PMC9780970
jpm-12-02061-g002.jpg
0.42854
d4150d89d89b4a7b81879a7f49bcdbd8
Pituitary MRI performed 6 months after delivery. (a). Non-contrast sagittal T2-weighted image. (b). Non-contrast coronal T2-weighted image. (c). Non-contrast sagittal T-weighted image. (d). Non-contrast coronal T1-weighted image. (e). Post-contrast sagittal T1-weighted image. (f). Post-contrast coronal T1-weighted image. The imaging aspect was the same as that at the beginning of the pregnancy; the pituitary adenoma was located in the left parapituitary in moderate high-signal T2-weighted (a,b), low-signal T1-weighted (c,d), and non-gadolinium enhanced (e,f). The diameter of the pituitary adenoma was 2/2 mm.
PMC9780970
jpm-12-02061-g003.jpg
0.576014
5452f1ec02244053a1b76f59d5b6e2b2
X-ray structure of the asymmetric part of SIL-BS.
PMC9781643
pharmaceutics-14-02838-g001.jpg
0.549886
1be107aefaf64a5dbfba1ec397a5a0e3
1D supramolecular chain in the crystal structure of SIL-BS formed by intermolecular hydrogen bonds N-H···O and O-H···O.
PMC9781643
pharmaceutics-14-02838-g002.jpg
0.415455
99cf22de49ab43299510987e85fa4236
The viability of HepG2 (A) and MCF7 (B) cells, assessed by XTT assay. Dose response curves used to determine IC50 of SIL-BS for HepG2 (C) and MCF7 (D) cells. Cells were treated for 48 h with increasing concentrations (4.68 μg/mL to 300 μg/mL) of SIL M or SIL-BS. Merged Live/Dead cell images of HepG2 and MCF7 cells exposed to SIL M and SIL-BS for 48 h (E). Live cells were stained with calcein AM (green) and dead cells are detected with propidium iodide (red). Scale bar: 200 μm. The percentage of the dead to total cell number determined by Live/Dead cell assay for HepG2 (F) and MCF7 (G). Statistical significance: ** p < 0.01, **** p < 0.001 vs. control, ### p < 0.001 and #### p < 0.0001 vs. corresponding SIL M.
PMC9781643
pharmaceutics-14-02838-g003.jpg
0.447297
0988c2f991674d3ea4bfd3c7aab8977e
UV-vis spectra of SIL M (a) and SIL-BS (b) during and after titration with protein (BSA) solution 10%.
PMC9781643
pharmaceutics-14-02838-g004.jpg
0.410761
8245198bb17e4a329a55b2ffd4016020
Emission spectra of the protein (BSA) during and after titration with SIL M (a) and SIL-BS (b) solutions 10−3 M.
PMC9781643
pharmaceutics-14-02838-g005.jpg
0.44845
f254db8b6b5849a5b522ab1570b68ff9
Stern–Volmer plot at λem = 338 nm obtained from steady-state measurements (λexc=280 nm) in PBS pH 7.4 (1% DMSO SIL-BS) (a) and the double-log plots of SIL-BS quenching effect on BSA fluorescence (b).
PMC9781643
pharmaceutics-14-02838-g006.jpg
0.436628
c3e6caaf34c24421a837f4f6d220bab6
Circular dichroism spectra of SIL M (a) and SIL-BS (b) in PBS solution of HSA at pH 7.4.
PMC9781643
pharmaceutics-14-02838-g007.jpg
0.415012
a7e5d6293a5f485f9da9c8aa32b1078a
Molecular rendering of the best docked pose showing the interaction between HSA (receptor) and SIL M ligand; global docking view and zoom image.
PMC9781643
pharmaceutics-14-02838-g008.jpg
0.421031
958fd1f8b0fc488c8df0fce351386cb0
Molecular rendering of the best docked pose showing the interaction between HSA (receptor) and SIL-BS ligand; global docking view and zoom image.
PMC9781643
pharmaceutics-14-02838-g009.jpg
0.451037
d8d7e4e539ef43448ba31244a0570e85
Molecular rendering of the best docked pose showing the interaction between MPRO receptor (COVID-19 main protease) and silatrane SIL M.
PMC9781643
pharmaceutics-14-02838-g010.jpg
0.439891
99afe3c739d0482b9d0091ef65ed86a1
The synthetic pathway to prepare the silatrane derivative SIL-BS.
PMC9781643
pharmaceutics-14-02838-sch001.jpg
0.518376
aa9cf2e2209f4b49b909dfb6a0214836
The bioreductive pathway of nitro group.
PMC9781643
pharmaceutics-14-02838-sch002.jpg
0.431866
cb60901ec8c54b3b9f394963acebc236
A general schema of the IBD mapping process that can help identify shared haplotypes carrying rare causal variants. Haplotypes of the same color are inherited from the same ancestor.
PMC9782725
nihms-1852986-f0001.jpg
0.407625
18dacbb699814bccbab067d9f9faa73d
R2 scores among clustering metrics across all simulations.
PMC9782725
nihms-1852986-f0002.jpg
0.545283
aa9cb7d24abe44d9b3356e405d1c6dd0
The effects of number of simulated clusters, false-positives, and false-negatives edges on the performance of algorithms in terms of (A) power, (B) AMI, and (C) modularity.
PMC9782725
nihms-1852986-f0003.jpg
0.414276
5963872cf8d04668ad94025ba4396b25
The recovery rate of local IBD graphs when tagging rare genetic variants captured by whole-exome sequencing data in the UK Biobank compared to a null model with randomized clusters.
PMC9782725
nihms-1852986-f0004.jpg
0.411412
f6c5cedeb11444a09378e952309ceb58
Relative size and the number of pests in the dataset. Relative scale represents the ratio of the pest pixel size to the whole image size; number represents the number of pests.
PMC9783619
fpls-13-973985-g001.jpg
0.506272
2171f8f9b1524b559f574d0015a8e5e6
The left image shows masking and adhesion between pests. The right image shows incomplete image annotation.
PMC9783619
fpls-13-973985-g002.jpg
0.421994
30f2cf3947204fa1990da5cd2fc18008
Structure diagram of the pest detection and counting framework based on the Pest-YOLO model.
PMC9783619
fpls-13-973985-g003.jpg
0.475594
a85922baea9d4ca6bd1d65cb01c55e6f
Adjacent block diagram detection; (x, y) and (p, q) are the coordinates of the bounding boxes’ vertices.
PMC9783619
fpls-13-973985-g004.jpg